Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
A Single-Arm Clinical Trial Investigating the Feasibility of a Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
A Single-Arm Clinical Trial Investigating the Feasibility of a Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Hybrid PET/MR in the Therapy of Cervical Cancer
Hybrid PET/MR in the Therapy of Cervical Cancer: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Hybrid PET/MR in the Therapy of Cervical Cancer
Hybrid PET/MR in the Therapy of Cervical Cancer: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Psychosexual Intervention for Gynecologic and Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
The Ohio State University Comprehensive Cancer Center
2006
mi
from 98109
Columbus, OH
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Psychosexual Intervention for Gynecologic and Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
The Ohio State University Comprehensive Cancer Center
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
705
mi
from 98109
Stanford, CA
Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Oregon Health & Science University, Casey Eye Institute
149
mi
from 98109
Portland, OR
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University, Casey Eye Institute
149
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Royal Victorian Eye and Ear Hospital
8191
mi
from 98109
Melbourne,
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Royal Victorian Eye and Ear Hospital
8191
mi
from 98109
Melbourne,
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Francis I. Proctor Foundation
682
mi
from 98109
San Francisco, CA
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Francis I. Proctor Foundation
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated:  12/31/1969
University of California Davis
628
mi
from 98109
Davis, CA
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated: 12/31/1969
University of California Davis
628
mi
from 98109
Davis, CA
Click here to add this to my saved trials
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated:  12/31/1969
University of California, Irivine
994
mi
from 98109
Irvine, CA
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated: 12/31/1969
University of California, Irivine
994
mi
from 98109
Irvine, CA
Click here to add this to my saved trials
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
1056
mi
from 98109
La Jolla, CA
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
1056
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
979
mi
from 98109
Los Angeles, CA
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
979
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Uterine Leiomyoma Treatment With Radiofrequency Ablation
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
A Randomized Trial of a Family Caregiver Palliative Care Intervention
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Center
959
mi
from 98109
Duarte, CA
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
A Randomized Trial of a Family Caregiver Palliative Care Intervention
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Center
959
mi
from 98109
Duarte, CA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Hospital and Medical Center
1112
mi
from 98109
Phoenix, AZ
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital and Medical Center
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
USC Norris Hospital and LAC+USC Medical Center
962
mi
from 98109
Los Angeles, CA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
USC Norris Hospital and LAC+USC Medical Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine Medical Center
984
mi
from 98109
Orange, CA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine Medical Center
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
The Hartford Hospital
2429
mi
from 98109
Hartford, CT
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
The Hartford Hospital
2429
mi
from 98109
Hartford, CT
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
The Hospital of Central Connecticut
2428
mi
from 98109
New Britain, CT
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
The Hospital of Central Connecticut
2428
mi
from 98109
New Britain, CT
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Northside Hospital
2174
mi
from 98109
Atlanta, GA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Northside Hospital
2174
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Women's Cancer Center
2073
mi
from 98109
Covington, LA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Women's Cancer Center
2073
mi
from 98109
Covington, LA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
University of Maryland Greenebaum Cancer Center
2327
mi
from 98109
Baltimore, MD
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
University of Maryland Greenebaum Cancer Center
2327
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital Cancer Center
2485
mi
from 98109
Boston, MA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital Cancer Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan-Kettering Cancer Institute
2401
mi
from 98109
New York, NY
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Institute
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Hope Women's Cancer Centers / Mission Hospital, Inc.
2186
mi
from 98109
Asheville, NC
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Hope Women's Cancer Centers / Mission Hospital, Inc.
2186
mi
from 98109
Asheville, NC
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Levine Cancer Institute
2281
mi
from 98109
Charlotte, NC
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Levine Cancer Institute
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Sanford Roger Maris Cancer Center
1194
mi
from 98109
Fargo, ND
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Sanford Roger Maris Cancer Center
1194
mi
from 98109
Fargo, ND
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
2008
mi
from 98109
Columbus, OH
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Peggy and Charles Oklahoma Cancer Center
1524
mi
from 98109
Oklahoma City, OK
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Peggy and Charles Oklahoma Cancer Center
1524
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Hollings Cancer Center, MUSC
2423
mi
from 98109
Charleston, SC
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Hollings Cancer Center, MUSC
2423
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Sanford Research/USD
1263
mi
from 98109
Sioux Falls, SD
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Sanford Research/USD
1263
mi
from 98109
Sioux Falls, SD
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospitals
2316
mi
from 98109
Falls Church, VA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospitals
2316
mi
from 98109
Falls Church, VA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Henrico Doctor's Hospital
2343
mi
from 98109
Richmond, VA
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Henrico Doctor's Hospital
2343
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Froedtert and the Medical College of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
University of Colorado
1026
mi
from 98109
Aurora, CO
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
University of Colorado
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Moffitt Cancer Center
2522
mi
from 98109
Tampa, FL
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Moffitt Cancer Center
2522
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Medizinische Universität Innsbruck
5313
mi
from 98109
Innsbruck,
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Medizinische Universität Innsbruck
5313
mi
from 98109
Innsbruck,
Click here to add this to my saved trials
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated:  12/31/1969
Washington University School of medecine
1721
mi
from 98109
Saint Louis, MO
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
Status: Enrolling
Updated: 12/31/1969
Washington University School of medecine
1721
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1117
mi
from 98109
Scottsdale, AZ
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1117
mi
from 98109
Scottsdale, AZ
Click here to add this to my saved trials
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1035
mi
from 98109
Sedona, AZ
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1035
mi
from 98109
Sedona, AZ
Click here to add this to my saved trials
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1220
mi
from 98109
Tucson, AZ
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1220
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1760
mi
from 98109
Hot Springs, AR
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1760
mi
from 98109
Hot Springs, AR
Click here to add this to my saved trials
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
669
mi
from 98109
Greenbrae, CA
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
669
mi
from 98109
Greenbrae, CA
Click here to add this to my saved trials